| Gene symbol | HGF | Synonyms | DFNB39, F-TCF, HGFB, HPTA, SF | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7q21.11 | dbXrefs | |
| Description | hepatocyte growth factor | ||||
| GTO ID | GTC1389 |
| Trial ID | NCT01422772 |
| Disease | Ischemic Heart Disease |
| Altered gene | HGF |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | VM202RY |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Open-label, Dose-escalation, Phase 1 Trial to Evaluate the Safety of VM202RY Gene Medicine Injected Into Myocardial Territory With Incomplete Revascularization During Coronary Artery Bypass Graft in Patients With Ischemic Heart Disease |
| Year | 2011 |
| Country | Korea,Republic of |
| Company sponsor | Helixmith Co., Ltd. |
| Other ID(s) | VM202RY-VM01 |
| Vector information | |||
|
|||
| Cohort1: dose level 1 | |||||||||||
|
|||||||||||
| Cohort2: dose level 2 | |||||||||||
|
|||||||||||
| Cohort3: dose level 3 | |||||||||||
|
|||||||||||